Position in AMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,602,145
+$47,088 QoQ
Shares Held
100,511
-6.5% QoQ
Ownership
0.476%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 80 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AMRN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $1,287,408,532 across 15 Drug Manufacturers - General names. AMRN ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,085,383 | $581,119,768 | |
| 2 | AMGN |
Amgen Inc
|
1,128,681 | $408,717,963 | |
| 3 | LLY |
ELI LILLY & Co
|
81,240 | $97,441,701 | |
| 4 | AZN |
Astrazeneca PLC
|
329,087 | $62,401,476 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
409,174 | $51,695,043 | |
| 6 | ABBV |
AbbVie Inc.
|
198,249 | $49,887,378 | |
| 7 | JNJ |
Johnson & Johnson
|
34,909 | $8,865,838 | |
| 8 | PFE |
Pfizer Inc
|
330,300 | $7,953,624 |
All Filings in AMRN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,602,145 | 100,511 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,555,057 | 107,542 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,551,905 | 111,168 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $983,962 | 60,071 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $957,369 | 59,024 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $835,169 | 1,855,933 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,065,131 | 2,173,737 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,499,410 | 2,380,016 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,095,958 | 3,037,621 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,020,995 | 3,394,377 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,770,334 | 3,184,293 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,175,311 | 3,451,426 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,743,469 | 4,826,445 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,341,474 | 5,560,983 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,040,034 | 4,165,318 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,202,832 | 2,020,947 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,764,934 | 1,184,520 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,782,529 | 2,061,559 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,364,368 | 998,329 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,217,950 | 1,219,206 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,748,835 | 1,997,451 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,496,581 | 402,026 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,607,964 | 737,825 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $519,935 | 123,500 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $12,394,017 | 1,791,043 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||